Investment will accelerate the development of Novus’ rapid point of care diagnostic technology and their groundbreaking 15 minute point of care sepsis test
DUBLIN, IRELAND, January 15, 2025 /EINPresswire.com/ — Novus Diagnostics Secures €4.6M in Equity Financing to Revolutionize Rapid Point-of-Care Diagnostics. Novus Diagnostics, a pioneering medical technology company, proudly announces the successful closing of a €4.6M equity financing round. Spearheaded by BVP Investments, Trinity Biotech, and Irrus Investments, this funding will accelerate the development of Novus’ cutting-edge rapid point-of-care diagnostic technology platform.